[Home ] [Archive]   [ فارسی ]  
:: ::
:: Volume 14, Issue 1 (March 2020) ::
Qom Univ Med Sci J 2020, 14(1): 1-10 Back to browse issues page
Assessment of Adherence to Anti-Tuberculosis Treatment among Patients with Tuberculosis in Qom Province in 2019 (Iran)
Seyed Abbas Hosseinalipour1 , Mahdi Mohammadi2 , Ahmad Rahbar3 , Abolfazl Mohammadbeigi4 , Amin Arabshahi1 , Siamak Mohebi 5
1- Department of Health Education and Health Promotion, School of Health, Qom University of Medical Sciences
2- Center for Disease Prevention and Control, Qom Health Center, Qom University of Medical Sciences
3- Department of Public Health, School of Health, Qom University of Medical Sciences
4- Department of Epidemiology and Biostatistics, School of Health, Qom University of Medical Sciences
5- Department of Health Education and Health Promotion, School of Health, Qom University of Medical Sciences , mohebisiamak@yahoo.com
Abstract:   (1738 Views)
Background and Objectives: Despite the implementation of effective preventive and therapeutic programs, the expected success in reducing and controlling tuberculosis (TB) cases, has not yet been achieved. The purpose of the current study was to evaluate adherence to anti-TB drug regimen and its related factors in patients with TB in Qom province.
Methods: This descriptive cross-sectional study, was conducted on TB patients in Qom province in 2019. According to the census method, 153 patients were entered to the study. Data were collected using 8-item Morisky Medication Adherence Scale. Data were analyzed by nonparametric chi square and Spearman correlation coefficient tests using SPSS software. The significance level of the tests, was considered less than 0.05.
Results: The mean and standard deviation of the score of adherence to the treatment of the patients under study, was 9.64±1.97. The results showed that 86.3% of the patients had a high adherence to the drug orders. There is a significant relationship between adherence to anti-TB drug regimen, type of disease, group therapy, HIV/AIDS, addiction, underlying disease, gender, and occupation (p<0.05). Other variables, such as clinical form of TB, nationality, residence area, and level of literacy had no effect on adherence to drug orders (p<0.05).
Conclusion: In this study, adherence to anti-TB drug regimen is high. The results of the causes of drug adherence, showed that direct monitoring of the treatment should be strengthened and communication with the patients should be improved.
Keywords: Compliance, Drug Regimen, Tuberculosis
Full-Text [PDF 841 kb]   (378 Downloads)    
Type of Study: Original Article | Subject: آموزش بهداشت
Received: 2019/08/31 | Accepted: 2020/02/15 | Published: 2020/03/29
1. 1. World Health Organization. Global tuberculosis report 2017. Geneva: World Health Organization; 2018. Link
2. The incidence of tuberculosis in Iran. Department of Tuberculosis and Leprosy Control. Available at: URL: http://tb-lep.behdasht.gov.ir/TB_Situation_in_Iran.aspx; 2019. Link
3. World Health Organization. Guidelines for treatment of drug- susceptible tuberculosis and patient care. Geneva: World Health Organization; 2018. Link
4. Nasehi M, Mirhaghani L. National guideline for the control of tuberculosis. 2nd ed. Tehran: Andishmand; 2011. P. 34-5. [Full Text in Persian] Link
5. Tesfahuneygn G, Medhin G, Legesse M. Adherence to Anti-tuberculosis treatment and treatment outcomes among tuberculosis patients in Alamata District, northeast Ethiopia. BMC Res Notes 2015;8:503. PMID: 26420164 [DOI:10.1186/s13104-015-1452-x]
6. Ogedegbe G, Schoenthaler A, Richardson T, Lewis L, Belue R, Espinosa E, et al. An RCT of the effect of motivational interviewing on medication adherence in hypertensive African Americans: Rationale and design. Contemp Clin Trials 2007;28(2):169-81. PMID: 16765100 [DOI:10.1016/j.cct.2006.04.002]
7. Munro SA, Lewin SA, Smith HJ, Engel ME, Fretheim A, Volmink J. Patient adherence to tuberculosis treatment: a systematic review of qualitative research. PLoS Med 2007;4(7):e238. PMID: 17676945 [DOI:10.1371/journal.pmed.0040238]
8. Naidoo P, Peltzer K, Louw J, Matseke G, Mchunu G, Tutshana B. Predictors of tuberculosis (TB) and antiretroviral (ARV) medication non-adherence in public primary care patients in South Africa: a cross sectional study. BMC Public Health. 2013;13:396. PMID: 23622516 [DOI:10.1186/1471-2458-13-396]
9. Widjanarko B, Gompelman M, Dijkers M, van der Werf MJ. Factors that influence treatment adherence of tuberculosis patients living in Java, Indonesia. Patient Prefer Adherence 2009;3:231-8. PMID: 19936166 [DOI:10.2147/PPA.S6020]
10. Méda ZC, Lin YT, Sombié I, Maré D, Morisky DE, Chen YM. Medication-adherence predictors among patients with tuberculosis or human immunodeficiency virus infection in Burkina Faso. J Microbiol Immunol Infect 2014;47(3):222-32. PMID: 23769812 [DOI:10.1016/j.jmii.2013.05.001]
11. Mekonnen HS, Azagew AW. Non-adherence to anti-tuberculosis treatment, reasons and associated factors among TB patients attending at Gondar town health centers, Northwest Ethiopia. BMC Res Notes 2018;11(1):691. PMID: 30285907 [DOI:10.1186/s13104-018-3789-4]
12. Shargie EB, Lindtjørn B. Determinants of treatment adherence among smear-positive pulmonary tuberculosis patients in Southern Ethiopia. PLoS Med 2007;4(2):e37. PMID: 17298164 [DOI:10.1371/journal.pmed.0040037]
13. Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens 2008;10(5):348-54. PMID: 18453793 [DOI:10.1111/j.1751-7176.2008.07572.x]
14. Ghanei Gheshlagh R, Ebadi A, Veisi Raygani AK, Nourozi Tabrizi K, Dalvandi A, Mahmoodi H. Determining concurrent validity of the morisky medication adherence scale in patients with type 2 diabetes. Iran J Rehabilit Res 2015;1(3):24-32. Link
15. World Health Organization. Economic cost of non-adherence to tb medicines resulting from stock-outs and loss to follow-up in the Philippines. Geneva: World Health Organization; 2019. Link
16. Jahani S, Elahi N, Shahinzade A, Hakim A, Latifi SM. Relation of knowledge and attitude with control of medication in tuberculosis patients in Ahvaz-Iran. J Gorgan Univ Med Sci 2011;12(4):80-4. [Full Text in Persian] Link
17. Khalili H, Dashti-Khavidak S, Sajadi S, Hajiabolbaghi M. Assessment of adherence to tuberculosis drug Regimen. Daru J Pharmaceut Sci 2008;16(1):47-50. Link
18. Mweemba P, Haruzivishe C, Siziya S, Chipimo PJ, Cristenson K, Johansson E. Knowledge, attitude and compliance with tuberculosis treatment, Lusaka, Zambia. Med J Zambia 2008;35(4):121-8. Link [DOI:10.4314/mjz.v35i4.56064]
19. Mkopi A, Range N, Lwilla F, Egwaga S, Schulze A, Geubbels E, et al. Adherence to tuberculosis therapy among patients receiving home-based directly observed treatment: evidence from the United Republic of Tanzania. PloS One 2012;7(12):e51828. PMID: 23284782 [DOI:10.1371/journal.pone.0051828]
20. Amuha MG, Kutyabami P, Kitutu FE, Odoi-Adome R, Kalyango JN. Non-adherence to anti-TB drugs among TB/HIV co-infected patients in Mbarara Hospital Uganda: Prevalence and associated factors. Afr Health Sci 2009;9(Suppl 1):S8-15. PMID: 20589161
21. Kulkarni PY, Akarte SV, Mankeshwar RM, Bhawalkar JS, Banerjee A, Kulkarni AD. Non. adherence of new pulmonary tuberculosis patients to anti. tuberculosis treatment. Ann Med Health Sci Res 2013;3(1):67-74. PMID: 23634333 [DOI:10.4103/2141-9248.109507]
22. Xu M, Markström U, Lyu J, Xu L. Detection of low adherence in rural tuberculosis patients in China: application of morisky medication adherence scale. Int J Environ Res Public Health 2017;14(3):E248. PMID: 28257075 [DOI:10.3390/ijerph14030248]
23. Krasniqi S, Jakupi A, Daci A, Tigani B, Jupolli-Krasniqi N, Pira M, et al. Tuberculosis treatment adherence of patients in Kosovo. Tuberc Res Treat 2017;2017:4850324. PMID: 29230326 [DOI:10.1155/2017/4850324]
24. Shahinzadh A, Elahi N, Jahani S, Hakim A. Relationship of personal- social and therapeutic factors with medication compliance in TB patients in Ahwaz. SSU J 2012;19(6):726-35. [Full Text in Persian] Link
25. Okanurak K, Kitayaporn D, Akarasewi P. Factors contributing to treatment success among tuberculosis patients: a prospective cohort study in Bangkok. Int J Tuberc Lung Dis 2008;12(10):1160-5. PMID: 18812046
26. Lei X, Huang K, Liu Q, Jie YF, Tang SL. Are tuberculosis patients adherent to prescribed treatments in China? Results of a prospective cohort study. Infect Dis Poverty 2016;5(1):38. PMID: 27146470 [DOI:10.1186/s40249-016-0134-9]
27. Naghib S, Abed Saeedi Z, Ezzati Z, Zayeri F. Self-efficacy and compliance with treatment regimen in tuberculosis patients in Kurdistan. Adv Nurs Midwifery 2013;22(77):26-31. [Full Text In Persian] Link
28. Jiba M, Zamani-Alavije F, Araban M, Salahshoori A, Jiba M, Haroni J. Social factors influencing treatment interruption in Tuberculosis Patients: a qualitative stud. J Health Field 2015;2(4): 26-34. [Full Text In Persian] Link
29. Cator M, Brassard P, Ducic S, Culman K. Factors related to non-compliance with active tuberculosis treatment in Montreal 1992-1995. Can J Public Health 2002;93(2):92-7. PMID: 11963527 [DOI:10.1007/BF03404545]
30. Kigozi G, Heunis C, Chikobvu P, Botha S, van Rensburg D. Factors influencing treatment default among tuberculosis patients in a high burden province of South Africa. Int J Infect Dis 2017;54:95-102. PMID: 27894985 [DOI:10.1016/j.ijid.2016.11.407]
31. Muture BN, Keraka MN, Kimuu PK, Kabiru EW, Ombeka VO, Oguya F. Factors associated with default from treatment among tuberculosis patients in Nairobi province, Kenya: a case control study. BMC Public Health 2011;11(1):696. PMID: 21906291 [DOI:10.1186/1471-2458-11-696]
32. Dooley KE, Lahlou O, Ghali I, Knudsen J, Elmessaoudi MD, Cherkaoui I, et al. Risk factors for tuberculosis treatment failure, default, or relapse and outcomes of retreatment in Morocco. BMC Public Health 2011;11(1):140. PMID: 21356062 [DOI:10.1186/1471-2458-11-140]
33. Adineh HA, Motametdi B, Veisi M, Bagheri S. Risk factors of tuberculosis treatment failure in South-East of Iran. J Gorgan Univ Med Sci 2014;16(2):50-6. [Full Text In Persian] Link
34. Marco A, Cayla JA, Serra M, Pedro R, Sanrama C, Guerrero R, et al. Predictors of adherence to tuberculosis treatment in a supervised therapy programme for prisoners before and after release. Study Group of Adherence to Tuberculosis Treatment of Prisoners. Eur Respir J 1998;12(4):967-71. PMID: 9817177 [DOI:10.1183/09031936.98.12040967]
35. Harries AD, Satyanarayana S, Kumar AM, Nagaraja SB, Isaakidis P, Malhotra S, et al. Epidemiology and interaction of diabetes mellitus and tuberculosis and challenges for care: a review. Public Health Action 2013;3(1):3-9. PMID: 26393066 [DOI:10.5588/pha.13.0024]
36. Das R, Baidya S, Das JC, Kumar S. A study of adherence to DOTS regimen among pulmonary tuberculosis patients in West Tripura District. Indian J Tuberc 2015;62(2):74-9. PMID: 26117475 [DOI:10.1016/j.ijtb.2015.04.005]
Send email to the article author

Add your comments about this article
Your username or Email:


XML   Persian Abstract   Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Hosseinalipour S A, Mohammadi M, Rahbar A, Mohammadbeigi A, Arabshahi A, Mohebi S. Assessment of Adherence to Anti-Tuberculosis Treatment among Patients with Tuberculosis in Qom Province in 2019 (Iran). Qom Univ Med Sci J. 2020; 14 (1) :1-10
URL: http://journal.muq.ac.ir/article-1-2596-en.html

Volume 14, Issue 1 (March 2020) Back to browse issues page
مجله دانشگاه علوم پزشکی قم Qom University of Medical Sciences Journal
Persian site map - English site map - Created in 0.07 seconds with 30 queries by YEKTAWEB 4256